Author:
Milde-Langosch Karin,Bamberger Ana-Maria,Rieck Gabriele,Kelp Bianca,Löning Thomas
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. Ruas M, Peters G: The p16INK4a/CDKN2A tumor suppressor and its relatives. Biochim Biophys Acta 1378: F115-F177, 1998
2. Quesnel B, Fenaux P, Philippe N, Fournier J, Bonneterre J, Preudhomme C, Peyrat JP: Analysis of p16 gene deletion and point mutation in breast carcinoma. Br J Cancer 72: 351-353, 1995
3. Berns EM, Klijn JG, Smid M, van Staveren IL, Gruis NA, Foekens JA: Infrequent CDKN2 (MTS1/p16) gene alterations in human primary breast cancer. Br J Cancer 72: 964-967, 1995
4. Musgrove EA, Lee CSL, Cornish AL, Swarbrick A, Sutherland RL: Antiprogest in inhibition of cell cycle progression in T47-D breast cancer cells is accompanied by induction of the cyclin-dependent kinase inhibitor p21. Mol Endocrinol 11: 54-66, 1997
5. Brenner AJ, Paladugu A, Wang H, Olopade OI, Dreyling MH, Aldaz CM: Preferential loss of expression of p16 (INK4a) rather than p19(ARF) in breast cancer. Clin Cancer Res 2: 1993-1998, 1996
Cited by
136 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献